This inventor holds 11 USPTO granted patents and 5 published patent applications. Top assignees: Technovax, Inc., Mannkind Corporation. Active years: 2014-2022.
Location History:
- Scarsdale, NY (US) (2014 - 2018)
- Tarrytown, NY (US) (2016 - 2018)
- Elmsford, NY (US) (2020 - 2022)
Company Filing History:
11 out of 11 
1 out of 286 
Years Active: 2014-2022
Title: Unveiling the Innovations of Jose M Galarza: A Pioneer in VLP Vaccines
Introduction
Jose M Galarza, a visionary inventor hailing from Elmsford, NY, has left an indelible mark in the field of virology with his groundbreaking work in the development of Virus-Like Particle (VLP) vaccines. His unwavering commitment to revolutionizing vaccine technologies has led to the creation of multiple patented inventions that have the potential to transform the landscape of preventive healthcare.
Latest Patents
Jose M Galarza's latest patents include the development of Universal VLP Influenza Vaccines, which feature influenza VLPs showcasing truncated, re-engineered, or remodeled HA molecules on their surface. Additionally, his Flavivirus and Alpha Virus VLPs offer innovative solutions by presenting antigenic flavivirus proteins on their surface, paving the way for advanced immunogenic compositions and vaccine strategies.
Career Highlights
Having accumulated a total of 11 patents, Jose M Galarza has demonstrated exceptional expertise in the realm of virology and vaccine development. Notably, he has made significant contributions during his tenures at Technovax, Inc. and MannKind Corporation, where his innovative mindset and pioneering spirit have propelled the advancement of VLP technologies.
Collaborations
Throughout his career, Jose M Galarza has collaborated with esteemed professionals in the field, including George R Martin and Demetrius Matassov. These collaborations have fostered a culture of knowledge exchange and innovation, leading to the successful realization of groundbreaking inventions in the realm of VLP vaccines.
Conclusion
In conclusion, Jose M Galarza stands out as a remarkable inventor whose inventive prowess and dedication to scientific advancement have reshaped the landscape of preventive healthcare. His invaluable contributions to virology and vaccine development serve as a testament to his unwavering commitment to innovation and improving global health outcomes.